IP Verse

Controlled Release Pharmaceutical Composition

PatentPatent Analysis

EP2345410

ASTELLAS PHARMA
Application Number
EP09817723A
Filing Date
Sep 28, 2009
Status
Granted And Under Opposition
Nov 27, 2020
Grant Date
Dec 30, 2020
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3791896B1
EP3318259B1
EP3725810B1

Biblio Summary

The patent EP2345410B1 was granted to Astellas Pharma on Dec 30, 2020 following the initial filing on Sep 28, 2009 under the application number EP09817723A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BRAND MURRAY FULLERSep 30, 2021ADMISSIBLE
TEVA PHARMACEUTICALSSep 30, 2021ADMISSIBLE
BULLE DRSep 29, 2021ADMISSIBLE
HAMM & WITTKOPPSep 29, 2021ADMISSIBLE
SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETISep 29, 2021ADMISSIBLE
SANDOZSep 23, 2021ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents